{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:37Z","timestamp":1772166037219,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Discriminating the total costs of hospitalizations from immunopreventable diseases in the population aged 20 to 59\u2009years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A population, observational, descriptive, retrospective study was conducted with secondary information from DATASUS to discriminate the hospitalizations associated with immunopreventable diseases in Brazil and their care costs, within the Scope of the SUS, between 2008 and 2018, in the economically active population (20 to 59\u2009years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>It was analyzed 127,746 hospitalizations for immunopreventable diseases, (27.92% of all hospitalizations) were observed in the adult population, totaled R$115,682,097.54 (29.72% of the total costs). Of this population studied, 51.48% were registered as male; 66.74% were associated with influenza disease; 16.05% to chickenpox\/herpes zoster infection and 7.55% to acute hepatitis B infections. The trend analysis of the time series of hospitalizations in this population showed a stationary trend.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 127,746 hospitalizations could be avoided with immunization, and 127,746 workers who could be working and not hospitalized. There were also R$115,682,097.54 that could be invested in other public health needs, which became necessary for the treatment of preventable diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-021-07029-4","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T05:02:27Z","timestamp":1636606947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospital costs of immunopreventable diseases in the economically active population in Brazil"],"prefix":"10.1186","volume":"21","author":[{"given":"\u00c9lide Sbardellotto M.","family":"da Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Hyeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane M. C. P.","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"7029_CR1","unstructured":"World Health Organization (WHO). International travel and health. Chapter 6. Dispon\u00edvel em: https:\/\/www.who.int\/ith\/ith-chapter6.pdf."},{"key":"7029_CR2","volume-title":"Health Surveillance Secretariat. Department of Communicable Diseases Surveillance. Manual of standards and procedures for vaccination \/ Ministry of Health, Health Surveillance Secretariat, Department of Surveillance of Communicable Diseases","author":"Brazil. Ministry of Health","year":"2014","unstructured":"Brazil. Ministry of Health. Health Surveillance Secretariat. Department of Communicable Diseases Surveillance. Manual of standards and procedures for vaccination \/ Ministry of Health, Health Surveillance Secretariat, Department of Surveillance of Communicable Diseases. Bras\u00edlia: Ministry of Health; 2014."},{"key":"7029_CR3","volume-title":"Health Surveillance Secretariat. Department of Communicable Diseases Surveillance. Cold Network Manual of the National Immunization Program \/ Ministry of Health, Health Surveillance Secretariat, Department of Surveillance of Communicable Diseases","author":"Brazil. Ministry of Health","year":"2017","unstructured":"Brazil. Ministry of Health. Health Surveillance Secretariat. Department of Communicable Diseases Surveillance. Cold Network Manual of the National Immunization Program \/ Ministry of Health, Health Surveillance Secretariat, Department of Surveillance of Communicable Diseases. 5th ed. Bras\u00edlia: Ministry of Health; 2017.","edition":"5"},{"issue":"3","key":"7029_CR4","first-page":"15","volume":"6","author":"DE Bloom","year":"2005","unstructured":"Bloom DE, Canning D, Weston M. The cost of vaccination. World Econ. 2005;6(3):15\u201339.","journal-title":"World Econ"},{"key":"7029_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","volume":"86","author":"FE Andre","year":"2008","unstructured":"Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86:140\u20136.","journal-title":"Bull World Health Organ"},{"key":"7029_CR6","first-page":"1","volume-title":"Vaccines","author":"SL Plotkin","year":"2004","unstructured":"Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders; 2004. p. 1\u201315.","edition":"4"},{"key":"7029_CR7","doi-asserted-by":"crossref","unstructured":"Dabbagh A, Eggers R, Cochi S, Dietz V, Strebel P, Cherian T. World Health Organization. A new global framework for immunization monitoring and surveillance. Dispon\u00edvel em: http:\/\/www.who.int\/bulletin\/volumes\/85\/12\/07-048223\/en\/.","DOI":"10.2471\/BLT.07.048223"},{"key":"7029_CR8","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","volume":"360","author":"SB Omer","year":"2009","unstructured":"Omer SB, Salmon DA, Orenstein WA, Dehart P, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360:1981\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"7029_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","volume":"36","author":"P Pezzotti","year":"2018","unstructured":"Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L, et al. The impact of immunization programs on 10 vaccine preventable diseases in italy: 1900\u20132015. Vaccine. 2018;36(11):1435\u201343.","journal-title":"Vaccine"},{"key":"7029_CR10","volume-title":"Surveillance standards for vaccine- preventable diseases, second edition","author":"World Health Organization (WHO)","year":"2018","unstructured":"World Health Organization (WHO). Surveillance standards for vaccine- preventable diseases, second edition. Geneva: World Health Organization; 2018. Dispon\u00edvel em: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/standards\/en"},{"key":"7029_CR11","volume-title":"National Vaccine Program Office. National Adult Immunization Plan","author":"U.S. Department of health and human services","year":"2010","unstructured":"U.S. Department of health and human services. National Vaccine Program Office. National Adult Immunization Plan. 2010. Dispon\u00edvel em: < https:\/\/www.hhs.gov\/sites\/default\/files\/nvpo\/national-adult-immunization-plan\/naip.pdf> Acessado em 16 de mar\u00e7o de 2021."},{"key":"7029_CR12","unstructured":"Brazil. Ministry of Health. Department of Health Care. Technical Note - General morbidity by place of hospitalization from 2008. Available from: http:\/\/tabnet.datasus.gov.br\/cgi\/sih\/Morb_geral_loc_int_2008.pdf\/ Accessed February 20, 2021."},{"issue":"3","key":"7029_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5123\/S1679-49742015000300024","volume":"24","author":"JLF Antunes","year":"2015","unstructured":"Antunes JLF, Cardoso MRA. Use of time series analysis in epidemiological studies. Epidemyol Serv Sa\u00fade Bras\u00edlia. 2015;24(3):565\u201376.","journal-title":"Epidemyol Serv Sa\u00fade Bras\u00edlia."},{"key":"7029_CR14","volume-title":"Handout of linear models in time series. Federal University of Minas Gerais - UFMG. Institute of Exact Sciences - ICEx. Department of Statistics - EST. London","author":"GC Franc","year":"2016","unstructured":"Franc GC. Handout of linear models in time series. Federal University of Minas Gerais - UFMG. Institute of Exact Sciences - ICEx. Department of Statistics - EST. London. 2016. Available in: ftp:\/\/est.ufmg.br\/pub\/glaura\/MLST\/Modelos%20Linear%20em%20S%E9ries%20Time.pdf"},{"key":"7029_CR15","volume-title":"Quantitative methods with stata: procedures, routines and analysis of results","author":"LP Favero","year":"2014","unstructured":"Favero LP. Quantitative methods with stata: procedures, routines and analysis of results. 1st ed. Rio de Janeiro: Elsevier; 2014. ISBN 978\u201385\u2013352-5157-9. Kindle edition","edition":"1"},{"key":"7029_CR16","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.vaccine.2019.04.051","volume":"37","author":"P Doyon-Plourde","year":"2019","unstructured":"Doyon-Plourde P, Fakih I, Tadount F, Fortin E, Quach C. Impact of influenza vaccination on healthcare utilization \u2013 a systematic review. Vaccine. 2019;37:3179\u201389.","journal-title":"Vaccine"},{"issue":"9","key":"7029_CR17","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4161\/21645515.2014.970879","volume":"10","author":"C Taddei","year":"2014","unstructured":"Taddei C, Ceccherini V, Niccolai G, Porchia BR, Boccalini S, Levi M, et al. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. Human Vaccines Immunotherapeutics. 2014;10(9):2612\u201322.","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"7029_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0140-6736(20)32657-X","volume":"397","author":"X Li","year":"2021","unstructured":"Li X, Mukandavire C, Cucunub\u00e1 ZM, Londono SE, Abbas K, Clapham HE, et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet. 2021;397:398\u2013408.","journal-title":"Lancet"},{"key":"7029_CR19","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.lanwpc.2021.100092","volume":"7","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zaid M, Xuan Z, Wang C, Gu H, Shi M, et al. Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China. Lancet Regional Health Western Pacific. 2021;7:100092.","journal-title":"Lancet Regional Health Western Pacific"},{"key":"7029_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(21)00025-8","volume":"397","author":"AL Cohen","year":"2021","unstructured":"Cohen AL, Patel MK, Cherian T. Vaccines work: a reason for celebration and renewed commitment. Lancet. 2021;397:351\u20132.","journal-title":"Lancet"},{"key":"7029_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33321\/cdi.2020.44.85","volume":"44","author":"A Bright","year":"2020","unstructured":"Bright A, Glynn-Robinson A-J, Kane S, Wright R, Sau N. Australian Government. Department of Health. The effect of COVID-19 public health measures on nationally notifiable diseases in Australia: preliminary analysis. Communicable Diseases Intelligence. 2020;44:1\u201316. https:\/\/doi.org\/10.33321\/cdi.2020.44.85 Acessado em 15 de mar\u00e7o de 2021.","journal-title":"Communicable Diseases Intelligence"},{"key":"7029_CR22","volume-title":"Immunization agenda 2030: a global strategy to leave no one behind","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO). Immunization agenda 2030: a global strategy to leave no one behind. 2020. Dispon\u00edvel em: https:\/\/www.who.int\/immunization\/immunization_agenda_2030\/en"},{"key":"7029_CR23","volume-title":"Global strategy for comprehensive vaccine-preventable disease (VPD) surveillance","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO). Global strategy for comprehensive vaccine-preventable disease (VPD) surveillance. 2020. Dispon\u00edvel em https:\/\/www.who.int\/publications\/m\/item\/global-strategy-for-comprehensive-vaccine-preventable-disease-(vpd)-surveilance"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-07029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-021-07029-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-07029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T05:02:58Z","timestamp":1636606978000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-07029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7029"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-07029-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-558143\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was submitted and accepted by the Ethical Committee by the Federal University of Paran\u00e1, at the number CAAE 15102619.6.0000.0102.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors responsible for this study consents in publication. The consent obtained from participants it was not applicable at this study because the data used are secondary cluster public data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are not competing interests by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1221"}}